Sarcopenia is present in a considerable proportion of patients with MIBC undergoing upfront cisplatin-based chemotherapy before planned RC. SMI decreases during treatment, but neither baseline SMI nor its kinetics is associated with response to chemotherapy.

Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer / Stangl-Kremser, J., Mari, A., D'Andrea, D., Kimura, S., Resch, I., Shariat, S.F., Klatte, T.. - In: UROLOGIA INTERNATIONALIS. - ISSN 0042-1138. - STAMPA. - 101:(2018), pp. 197-200. [10.1159/000489013]

Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer

Mari, Andrea;
2018

Abstract

Sarcopenia is present in a considerable proportion of patients with MIBC undergoing upfront cisplatin-based chemotherapy before planned RC. SMI decreases during treatment, but neither baseline SMI nor its kinetics is associated with response to chemotherapy.
2018
101
197
200
Stangl-Kremser, Judith; Mari, Andrea; D'Andrea, David; Kimura, Shoji; Resch, Irene; Shariat, Shahrokh F.; Klatte, Tobias
1a - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
38.pdf

Accesso chiuso

Descrizione: Articolo principale
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 130.49 kB
Formato Adobe PDF
  Richiedi una copia all'autore
130.49 kB Adobe PDF   Richiedi una copia all'autore

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1153906
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 13
social impact